Initial experience of correlating parameters of intravoxel incoherent motion and dynamic contrast-enhanced magnetic resonance imaging at 3.0 T in nasopharyngeal carcinoma

European Radiology

Volumn 24, Issue 12, 2014, Pages 3076-3087

  Jia, Qian Jun ^a   Zhang, Shui Xing ^a   Chen, Wen Bo ^a   Liang, Long ^a   Zhou, Zheng Gen ^a   Qiu, Qian Hui ^a   Liu, Zai Yi ^a   Zeng, Qiong Xin ^a   Liang, Chang Hong ^a  

^a GUANGDONG PROVINCIAL PEOPLE'S HOSPITAL   (China)

Author keywords

Diffusion weighted MR imaging; Dynamic contrast enhanced MR imaging; Intravoxel incoherent motion (IVIM); Nasopharyngeal carcinoma; Perfusion

Indexed keywords

GADOLINIUM PENTETATE MEGLUMINE; CONTRAST MEDIUM;

ADULT; AGED; ARTICLE; BLAND ALTMAN ANALYSIS; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; CORRELATION ANALYSIS; CORRELATION COEFFICIENT; DIFFUSION WEIGHTED IMAGING; ENHANCEMENT AMPLITUDE; ENHANCEMENT RATIO; FEMALE; HUMAN; IMAGE ANALYSIS; INTEROBSERVER REPRODUCIBILITY; INTRAOBSERVER REPRODUCIBILITY; INTRAVOXEL INCOHERENT MOTION; MALE; MAXIMUM SLOPE OF INCREASE; MOLECULAR DIFFUSION; NASOPHARYNX CARCINOMA; NUCLEAR MAGNETIC RESONANCE IMAGING; PERFUSION FRACTION; PERFUSION RELATED DIFFUSION; PROSPECTIVE STUDY; RADIOLOGICAL PARAMETERS; REPRODUCIBILITY; STATISTICAL MODEL; TISSUE PERFUSION; TUMOR BLOOD FLOW; DIAGNOSTIC USE; DIFFUSION; EVALUATION STUDY; FEASIBILITY STUDY; MIDDLE AGED; MOTION; NASOPHARYNGEAL NEOPLASMS; OBSERVER VARIATION; PROCEDURES; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; CONTRAST MEDIA; DIFFUSION; DIFFUSION MAGNETIC RESONANCE IMAGING; FEASIBILITY STUDIES; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MOTION; NASOPHARYNGEAL NEOPLASMS; OBSERVER VARIATION; PROSPECTIVE STUDIES; REPRODUCIBILITY OF RESULTS;

EID: 84911805687     PISSN: 09387994     EISSN: 14321084     Source Type: Journal    
DOI: 10.1007/s00330-014-3343-2     Document Type: Article

References (32)

1. Parkin DM, Bray F, Ferlay J, Pisani P (2005) Global cancer statistics, 2002. CA Cancer J Clin 55:74–108
2. Fu Y-S, Wenig BM, Abemayor E, Wenig B (2001) Head and neck pathology with clinical correlations. Philadelphia (Pa) 7:602
3. Jin G, Su D, Liu L, Zhu X, Xie D, Zhao W (2011) The accuracy of computed tomographic perfusion in detecting recurrent nasopharyngeal carcinoma after radiation therapy. J Comput Assist Tomogr 35:26–30
4. Huang B, Wong CS, Whitcher B et al (2013) Dynamic contrast-enhanced magnetic resonance imaging for characterising nasopharyngeal carcinoma: comparison of semiquantitative and quantitative parameters and correlation with tumour stage. Eur Radiol 23:1495–1502
5. Semiz Oysu A, Ayanoglu E, Kodalli N, Oysu C, Uneri C, Erzen C (2005) Dynamic contrast-enhanced MRI in the differentiation of posttreatment fibrosis from recurrent carcinoma of the head and neck. Clin Imaging 29:307–312
6. Lee FK, King AD, Ma BB, Yeung DK (2012) Dynamic contrast enhancement magnetic resonance imaging (DCE-MRI) for differential diagnosis in head and neck cancers. Eur J Radiol 81:784–788
7. Liu C, Liang C, Liu Z, Zhang S, Huang B (2013) Intravoxel incoherent motion (IVIM) in evaluation of breast lesions: comparison with conventional DWI. Eur J Radiol 82:e782–e789
8. Le Bihan D, Breton E, Lallemand D, Aubin ML, Vignaud J, Laval-Jeantet M (1988) Separation of diffusion and perfusion in intravoxel incoherent motion MR imaging. Radiology 168:497–505
9. Le Bihan D, Turner R, MacFall JR (1989) Effects of intravoxel incoherent motions (IVIM) in steady-state free precession (SSFP) imaging: application to molecular diffusion imaging. Magn Reson Med 10:324–337
10. Le Bihan D, Turner R (1992) The capillary network: a link between IVIM and classical perfusion. Magn Reson Med 27:171–178
11. Federau C, O’Brien K, Meuli R, Hagmann P, Maeder P (2013) Measuring brain perfusion with intravoxel incoherent motion (IVIM): initial clinical experience. J Magn Reson Imaging. doi:10.1002/jmri.24195
12. Sumi M, Van Cauteren M, Sumi T, Obara M, Ichikawa Y, Nakamura T (2012) Salivary gland tumors: use of intravoxel incoherent motion MR imaging for assessment of diffusion and perfusion for the differentiation of benign from malignant tumors. Radiology 263:770–777
13. Sumi M, Nakamura T (2013) Head and neck tumours: combined MRI assessment based on IVIM and TIC analyses for the differentiation of tumors of different histological types. Eur Radiol. doi:10.1007/s00330-013-3002-z
14. Lai V, Li X, Lee VH, Lam KO, Chan Q, Khong PL (2013) Intravoxel incoherent motion MR imaging: comparison of diffusion and perfusion characteristics between nasopharyngeal carcinoma and post-chemoradiation fibrosis. Eur Radiol. doi:10.1007/s00330-013-2889-8
15. Lai V, Li X, Lee VH et al (2013) Nasopharyngeal carcinoma: comparison of diffusion and perfusion characteristics between different tumour stages using intravoxel incoherent motion MR imaging. Eur Radiol. doi:10.1007/s00330-013-2995-7
16. Luciani A, Vignaud A, Cavet M et al (2008) Liver cirrhosis: intravoxel incoherent motion MR imaging–pilot study. Radiology 249:891–899
17. Pang Y, Turkbey B, Bernardo M et al (2013) Intravoxel incoherent motion MR imaging for prostate cancer: an evaluation of perfusion fraction and diffusion coefficient derived from different b-value combinations. Magn Reson Med 69:553–562
18. Bland JM, Altman DG (1986) Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1:307–310
19. Zhang JL, Sigmund EE, Chandarana H et al (2010) Variability of renal apparent diffusion coefficients: limitations of the monoexponential model for diffusion quantification. Radiology 254:783–792
20. Koh DM, Collins DJ, Orton MR (2011) Intravoxel incoherent motion in body diffusion-weighted MRI: reality and challenges. AJR Am J Roentgenol 196:1351–1361
21. Lewin M, Fartoux L, Vignaud A, Arrive L, Menu Y, Rosmorduc O (2011) The diffusion-weighted imaging perfusion fraction f is a potential marker of sorafenib treatment in advanced hepatocellular carcinoma: a pilot study. Eur Radiol 21:281–290
22. Lee HJ, Rha SY, Chung YE et al (2013) Tumor perfusion-related parameter of diffusion-weighted magnetic resonance imaging: correlation with histological microvessel density. Magn Reson Med. doi:10.1002/mrm.24810
23. Thomassin-Naggara I, Bazot M, Darai E, Callard P, Thomassin J, Cuenod CA (2008) Epithelial ovarian tumors: value of dynamic contrast-enhanced MR imaging and correlation with tumor angiogenesis. Radiology 248:148–159
24. Patel J, Sigmund EE, Rusinek H, Oei M, Babb JS, Taouli B (2010) Diagnosis of cirrhosis with intravoxel incoherent motion diffusion MRI and dynamic contrast-enhanced MRI alone and in combination: preliminary experience. J Magn Reson Imaging 31:589–600
25. Guiu B, Petit JM, Capitan V et al (2012) Intravoxel incoherent motion diffusion-weighted imaging in nonalcoholic fatty liver disease: a 3.0-T MR study. Radiology 265:96–103
26. Miyazaki K, Collins DJ, Walker-Samuel S et al (2008) Quantitative mapping of hepatic perfusion index using MR imaging: a potential reproducible tool for assessing tumour response to treatment with the antiangiogenic compound BIBF 1120, a potent triple angiokinase inhibitor. Eur Radiol 18:1414–1421
27. Pierpaoli C, Basser PJ (1996) Toward a quantitative assessment of diffusion anisotropy. Magn Reson Med 36:893–906
28. Jones DK (2004) The effect of gradient sampling schemes on measures derived from diffusion tensor MRI: a Monte Carlo study. Magn Reson Med 51:807–815
29. Henkelman RM (1990) Does IVIM measure classical perfusion? Magn Reson Med 16:470–475
30. Wirestam R, Borg M, Brockstedt S, Lindgren A, Holtas S, Stahlberg F (2001) Perfusion-related parameters in intravoxel incoherent motion MR imaging compared with CBV and CBF measured by dynamic susceptibility-contrast MR technique. Acta Radiol 42:123–128
31. Edelman RR, Mattle HP, Atkinson DJ et al (1990) Cerebral blood flow: assessment with dynamic contrast-enhanced T2*-weighted MR imaging at 1.5 T. Radiology 176:211–220
32. King AD, Ahuja AT, Yeung DK et al (2007) Malignant cervical lymphadenopathy: diagnostic accuracy of diffusion-weighted MR imaging. Radiology 245:806–813